Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Biotech
Bicycle lays off staff as Genentech rides away from R&D pact
The layoffs, which are part of a push to cut spending by 30%, follow Genentech’s termination of an oncology collaboration with the biotech.
Nick Paul Taylor
Aug 8, 2025 8:50am
Gilead hands back one Arcus cancer candidate from $725M deal
Aug 7, 2025 6:35am
Lilly's oral GLP-1 tied to 12% weight loss in phase 3 trial
Aug 7, 2025 6:30am
Kaken strengthens late-stage HAE portfolio with $32M Astria deal
Aug 6, 2025 10:21am
HMNC recalibrates precision depression push after phase 2b miss
Aug 5, 2025 10:38am
Vertex drops asset in acute pain after phase 2 fail
Aug 4, 2025 5:34pm